Dashboard
Manage Tickers

ME23andMe Holding Co.

Nasdaq 23andme.com


$ 0.35 $ 0.04 (12.91 %)    

Wednesday, 18-Sep-2024 14:08:19 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 476.45 $ 1.89 (0.4 %)
DIA $ 418.50 $ 1.60 (0.38 %)
SPY $ 565.48 $ 1.62 (0.29 %)
TLT $ 100.49 $ 0.17 (0.17 %)
GLD $ 239.97 $ 1.78 (0.75 %)
$ 0.3412
$ 0.31
$ 0.35 x 300
-- x --
$ 0.31 - $ 0.36
$ 0.29 - $ 1.10
2,227,406
na
172.65M
$ 1.84
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-30-2024 03-31-2024 10-K
3 02-07-2024 12-31-2023 10-Q
4 11-08-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-25-2023 03-31-2023 10-K
7 02-08-2023 12-31-2022 10-Q
8 11-07-2022 09-30-2022 10-Q
9 08-09-2022 06-30-2022 10-Q
10 05-27-2022 03-31-2022 10-K
11 02-11-2022 12-31-2021 10-Q
12 11-10-2021 09-30-2021 10-Q
13 08-13-2021 06-30-2021 10-Q
14 06-03-2021 03-31-2021 10-Q
15 03-24-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

independent-board-members-of-penny-stock-23andme-resign-call-out-ceo-anne-wojcicki-for-not-actionable-proposal-despite-ample-time
Independent Board Members Of Penny Stock 2...
09/18/2024 12:51:49

23andMe's independent board members resigned after months of waiting for Anne Wojcicki's fully financed proposal to tak...

general-mills-steelcase-and-3-stocks-to-watch-heading-into-wednesday
General Mills, Steelcase And 3 Stocks To W...
09/18/2024 06:13:09

independent-directors-of-23andme-board-cited-lack-of-progress-on-ceo-anne-wojcickis-proposal-and-strategic-differences-on-companys-future-direction
Independent Directors Of 23andMe Board Cit...
09/17/2024 20:28:07

23andme-independent-directors-tendered-resignations-effective-immediately
23andMe Independent Directors Tendered Res...
09/17/2024 20:27:24

reported-sunday-23andme-announced-nonclinical-data-supporting-the-anti-tumor-activity-of-23me-01473-antibody-targeting-nkg2d-ligand-ulbp6-at-the-esmo-congress
Reported Sunday, 23andMe Announced Nonclin...
09/16/2024 09:27:36

23ME-01473 inhibited tumor growth in a patient-derived xenograft mouse model of non-small cell lung cancer.Elevated levels of s...

reported-earlier-23andme-therapeutics-releases-phase-2-findings-for-two-additional-cancer-cohorts-and-correlation-biomarker-data-from-the-23me-00610-trial
Reported Earlier, 23andMe Therapeutics Rel...
09/16/2024 07:28:43

23ME-00610 monotherapy demonstrates preliminary evidence of clinical benefit in clear-cell renal-cell carcinoma, with one con...

why-affirm-shares-are-trading-higher-by-around-18-here-are-20-stocks-moving-premarket
Why Affirm Shares Are Trading Higher By Ar...
08/29/2024 09:37:19

lemonaid-health-is-now-offering-ozempic-wegovy-and-compounded-semaglutide-through-a-weight-loss-program-on-its-telehealth-platform-providing-consumers-with-access-to-affordable-weight-management-care-through-a-convenient-subscription-based-model
Lemonaid Health Is Now Offering Ozempic, W...
08/28/2024 11:31:28

23andme-holding-q1-2025-gaap-eps-014-sales-40000m-miss-52050m-estimate
23andMe Holding Q1 2025 GAAP EPS $(0.14), ...
08/08/2024 20:22:48

23andMe Holding (NASDAQ:ME) reported quarterly losses of $(0.14) per share. The company reported quarterly sales of $40.000 mi...

23andme-special-committee-responds-to-ceos-take-private-proposal-says-in-the-absence-of-a-revised-offer-at-a-more-appropriate-price-per-share-that-meets-the-other-requirements-set-forth-above-we-will-pursue-other-alternatives-in-striving-to-maximize-value-for-all-shareholders
23andMe Special Committee Responds To CEO'...
08/02/2024 12:08:22

23andme-receives-preliminary-non-binding-proposal-from-ceo-anne-wojcicki-to-acquire-all-outstanding-shares-not-owned-by-her-or-affiliates-for-040-per-share
23andMe Receives Preliminary Non-Binding P...
08/01/2024 12:02:33

Special Committee Reviewing Proposal With Wells Fargo As Financial Advisor And Dechert LLP As Legal Advisor

23andme-in-collaboration-with-20-lung-cancer-advocacy-organizations-announced-a-new-study-to-help-advance-research-in-lung-cancer
23andMe In Collaboration With 20 Lung Canc...
07/25/2024 11:36:06

The focus of the Lung Cancer Genetics Study is to better understand the genetics of people with lung cancer in order to improve...

23andme-and-nightingale-health-announced-a-strategic-collaboration-to-pilot-nightingale-healths-blood-metabolomics-panel-with-a-cohort-of-23andme-members
23andMe And Nightingale Health Announced A...
06/28/2024 11:33:12

As part of the pilot, 23andMe will offer up to 5,000 23andMe+ Premium and Total Health members the opportunity to receive blood...

looking-into-23andme-holdings-recent-short-interest
Looking Into 23andMe Holding's Recent Shor...
06/12/2024 19:15:21

Core News & Articles
Canada Authority Says Canada And UK Privac...
06/10/2024 14:12:14

- Reuters

23andme-therapeutics-present-preliminary-phase-2-safety-and-efficacy-results-for-23me-00610-targeting-cd200r1-at-the-2024-asco-annual-meeting
23andMe Therapeutics Present Preliminary P...
06/03/2024 12:21:59

– 23ME-00610 monotherapy demonstrates preliminary evidence of clinical benefit, including one confirmed partial response – 23ME...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
05/23/2024 20:31:02

23andme-board-on-mar-28-formed-special-committee-to-review-strategic-alternatives-for-maximizing-shareholder-value-on-apr-18-announced-ceo-anne-wojcicki-considering-proposal-to-acquire-remaining-outstanding-shares-says-in-light-of-review-not-providing-guidance
23andMe Board On Mar. 28 Formed Special Co...
05/23/2024 20:11:25

23andme-holding-q4-2024-gaap-eps-043-sales-64028m-beat-55822m-estimate
23andMe Holding Q4 2024 GAAP EPS $(0.43), ...
05/23/2024 20:07:32

23andMe Holding (NASDAQ:ME) reported quarterly losses of $(0.43) per share. The company reported quarterly sales of $64.028 mi...

Core News & Articles
Petros Pharmaceuticals Launches U.S. Distr...
05/14/2024 13:23:12

Lemonaid Health will offer customers more affordable access to branded ED medication STENDRA that may be taken as early as ~15 ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION